Moxifloxacin-loaded in situ synthesized Bioceramic/Poly(L-lactide-co-ε-caprolactone) composite scaffolds for treatment of osteomyelitis and orthopedic regeneration
Radwan, Noha H; Nasr, Maha; Awad, Gehanne A S; Aziz Ishak, Rania;
Abstract
High local intraosseous levels of antimicrobial agents are required for adequate long-term treatment of chronic osteomyelitis (OM). In this study, biodegradable composite scaffolds of poly-lactide-co-ε-caprolactone/calcium phosphate (CaP) were in-situ synthesized using two different polymer grades and synthesis pathways and compared to composites prepared by pre-formed (commercially available) CaP for delivery of the antibiotic moxifloxacin hydrochloride (MOX). Phase identification and characterization by Fourier transform infra-red (FTIR) spectroscopy, X-ray powder diffraction (XRPD) and scanning electron microscope (SEM) confirmed the successful formation of different CaP phases within the biodegradable polymer matrix. The selected in-situ formed CaP scaffold showed a sustained release for MOX for six weeks and adequate porosity. Cell viability study on MG-63 osteoblast-like cells revealed that the selected composite scaffold maintained the cellular proliferation and differentiation. Moreover, it was able to diminish the bacterial load, inflammation and sequestrum formation in the bones of OM-induced animals. The results of the present work deduce that the selected in-situ formed CaP composite scaffold is a propitious candidate for OM treatment, and further clinical experiments are recommended.
Other data
Title | Moxifloxacin-loaded in situ synthesized Bioceramic/Poly(L-lactide-co-ε-caprolactone) composite scaffolds for treatment of osteomyelitis and orthopedic regeneration | Authors | Radwan, Noha H; Nasr, Maha ; Awad, Gehanne A S; Aziz Ishak, Rania | Keywords | Calcium Phosphate;Composites;Moxifloxacin hydrochloride;Osteomyelitis;Poly-lactide-co-ε-caprolactone;Scaffolds | Issue Date | 30-Apr-2021 | Publisher | ELSEVIER | Journal | International Journal of Pharmaceutics | Volume | 602 | ISSN | 03785173 | DOI | 10.1016/j.ijpharm.2021.120662 | PubMed ID | 33933641 | Scopus ID | 2-s2.0-85105327851 | Web of science ID | WOS:000657600400001 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.